Evermay Wealth Management LLC Has $615,000 Holdings in Elevance Health, Inc. (NYSE:ELV)

Evermay Wealth Management LLC lifted its position in shares of Elevance Health, Inc. (NYSE:ELV) by 5.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,667 shares of the company’s stock after purchasing an additional 89 shares during the period. Evermay Wealth Management LLC’s holdings in Elevance Health were worth $615,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently added to or reduced their stakes in ELV. Quarry LP acquired a new position in Elevance Health during the second quarter valued at approximately $73,000. Sanctuary Advisors LLC bought a new position in Elevance Health in the second quarter valued at about $12,805,000. Healthcare of Ontario Pension Plan Trust Fund raised its stake in Elevance Health by 41.6% during the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 50,000 shares of the company’s stock worth $27,093,000 after acquiring an additional 14,700 shares in the last quarter. Centaurus Financial Inc. lifted its holdings in shares of Elevance Health by 66.9% in the second quarter. Centaurus Financial Inc. now owns 918 shares of the company’s stock worth $498,000 after acquiring an additional 368 shares during the last quarter. Finally, Czech National Bank boosted its stake in shares of Elevance Health by 6.7% in the 3rd quarter. Czech National Bank now owns 47,237 shares of the company’s stock valued at $24,563,000 after purchasing an additional 2,947 shares in the last quarter. Institutional investors own 89.24% of the company’s stock.

Elevance Health Price Performance

Shares of NYSE ELV opened at $395.82 on Friday. The company has a market capitalization of $91.80 billion, a PE ratio of 15.46, a PEG ratio of 1.20 and a beta of 0.84. The company has a quick ratio of 1.50, a current ratio of 1.45 and a debt-to-equity ratio of 0.71. The stock’s 50 day moving average price is $386.50 and its 200-day moving average price is $457.81. Elevance Health, Inc. has a twelve month low of $362.21 and a twelve month high of $567.26.

Elevance Health (NYSE:ELV) last announced its quarterly earnings data on Thursday, January 23rd. The company reported $3.84 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.80 by $0.04. Elevance Health had a return on equity of 18.28% and a net margin of 3.38%. On average, equities analysts anticipate that Elevance Health, Inc. will post 34.09 EPS for the current year.

Elevance Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 25th. Shareholders of record on Monday, March 10th will be given a $1.71 dividend. This is a positive change from Elevance Health’s previous quarterly dividend of $1.63. The ex-dividend date is Monday, March 10th. This represents a $6.84 annualized dividend and a yield of 1.73%. Elevance Health’s payout ratio is currently 25.46%.

Analyst Ratings Changes

Several research analysts have recently issued reports on ELV shares. StockNews.com downgraded shares of Elevance Health from a “buy” rating to a “hold” rating in a report on Monday, January 27th. Raymond James set a $485.00 target price on Elevance Health in a report on Friday, October 18th. Argus reissued a “hold” rating and set a $405.40 price target on shares of Elevance Health in a research note on Wednesday. TD Cowen lowered their price objective on Elevance Health from $589.00 to $484.00 and set a “buy” rating for the company in a research note on Monday, October 21st. Finally, Barclays lifted their target price on shares of Elevance Health from $501.00 to $512.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Four analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Elevance Health has a consensus rating of “Moderate Buy” and an average price target of $517.03.

Elevance Health Profile

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.